Details

DSEN Abstract: Comparative Efficacy and Safety of Ultra-Long-, Long-, and Intermediate-Acting and Biosimilar Insulins for Type 1 Diabetes: A Systematic Review and Network Meta-Analysis - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Apr 12, 2026 · edition #8
Timestamp
2026-04-12T21:52:31.858Z
Language
en
Original URL
https://cihr-irsc.gc.ca/e/54245.html?wbdisable=true
Replay URL
https://replay.healtharchive.ca/job-8/20260412215231/https://cihr-irsc.gc.ca/e/54245.html?wbdisable=true#ha_snapshot=1170236
ID
1170236
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

ViewView diffRaw HTML ↗Metadata JSON ↗CiteReport issueAll snapshots

Other snapshots

Archived page preview